The World Health Organization welcomes the encouraging news about Corona vaccines

Today, Monday, the Director of the World Health Organization, Tedros Adhanom Ghebreyesus, welcomed what he described as "encouraging news" in terms of reaching vaccines against the emerging corona virus (Covid-19), but he stressed the need not to be complacent.

"It is a dangerous virus that can attack all body systems," Tedros said at a press conference.

The company, Moderna, announced today that its experimental vaccine to prevent corona virus is 94.5 percent effective based on temporary data from a clinical trial at a late stage, making Moderna the second American pharmaceutical company to announce results far exceeding expectations within a week. .

In addition to the vaccine from the American company, Pfizer, and the German company, Biontech, which showed more than 90 percent efficacy and awaiting further safety data and regulatory review, the United States could obtain two vaccines authorized for use in emergency situations next December.

Up to 60 million doses of vaccines will be available by the end of the year.

Next year, the U.S. government can get more than a billion doses from just the two companies, which is too much for the country's 330 million residents.

"We will have a vaccine that can stop Covid-19," said the president of Moderna, Stephen Hoge.

Moderna expects to have enough safety data to authorize the vaccine in the United States within the next week.

The company explained that one of the main advantages of its vaccine is that it does not need to be stored in very cold temperatures, which makes it easier to distribute.

She expected the vaccine to be stable at normal coolant temperatures from 2 to 8 degrees Celsius for 30 days and could be stored for up to six months at minus 20 degrees Celsius.

Follow our latest local and sports news, and the latest political and economic developments via Google news